Synthego Corporation
- UEI
- RNDBNJAKTJC9
- CAGE
- 7W9H6
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- synthego.com
- Founded
- 2012
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$14,368 |
| FY2024 | $175,455 |
| FY2023 | $314,451 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Synthego Corporation, doing business as Synthego Corp, is a self-certified small disadvantaged business and manufacturer of gene editing products based in Redwood City, California. The company specializes in providing genome engineering solutions, including custom cell line development, gene knockout and knock-in services, and CRISPR libraries and reagents to support biomedical research efforts across multiple government agencies. Synthego has established itself as a leading provider of advanced genetic engineering tools and services, leveraging its expertise in CRISPR technology to accelerate scientific discovery and drug development.
Since its registration in SAM.gov in June 2017, Synthego has been awarded over 30 prime federal contracts, primarily from various institutes within the National Institutes of Health (NIH). These contracts have ranged from small purchase orders for specific cell lines or gene editing services to larger awards for comprehensive genome-wide screening libraries. Notable examples include a $356,221 contract with the National Center for Advancing Translational Sciences for a Whole Human Genome Arrayed CRISPR Screening Library, and multiple awards from the National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, and National Cancer Institute for custom cell line engineering and CRISPR-based gene editing services. Synthego has also received contracts from other agencies such as the Department of Veterans Affairs and the Environmental Protection Agency. While most contracts were not set aside, some were designated as total small business set-asides. The company's work primarily supports research in areas such as translational science, infectious diseases, environmental health, and addiction studies, demonstrating its crucial role in advancing federal biomedical research initiatives.
Quick answers
Is Synthego Corporation registered in SAM.gov?
Synthego Corporation's SAM.gov registration expired on October 21, 2025.
How much has Synthego Corporation received in federal contracts?
Federal contracts obligated $475,538 to Synthego Corporation in fiscal years 2023 through 2027.
What is Synthego Corporation's most recent federal award?
Synthego Corporation's most recent federal contract award is Niaaa - gene variant editing services (75N94024P00323), from National Institute of Child Health and Human Development (NIH), on June 7, 2024.
On GovTribe
See Synthego Corporation's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors